Pokethebear

NEMUS Bioscience - Possible Entry for medical pain therapy

OTC:NMUS   None
NMUS
About: NEMUS Bioscience, Inc. ( NMUS ) , focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need.

Entry better on 4h / 1d vs 1w chart here and another CBD stock missed entry for self note.

Watching to see if breakout from current level. Future entry TBD. Watch out for random "cannabinoid" being said in your meetings today with TESLA. @pokethebear

I do not advocate THC use and consider the current opioid epidemic to be another on-ramp for alternative break-though medicine. Lipitor to Pfizer, Embrel to AMGEN? 10-1 baggers/3 yr focus. #pharmaindustry. 65% insider owned & no sells on record.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。